Xf. Sun et al., Niemann-Pick C variant detection by altered sphingolipid trafficking and correlation with mutations within a specific domain of NPC1, AM J HU GEN, 68(6), 2001, pp. 1361-1372
Citations number
37
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Molecular Biology & Genetics
Niemann-Pick disease type C (NPC) is a fatal, autosomal recessive lipidosis
characterized by lysosomal accumulation of unesterified cholesterol and mu
ltiple neurological symptoms, such as vertical supranuclear ophthalmoplegia
, progressive ataxia, and dementia. More than 90% of cases of NPC are due t
o a defect in Niemann-Pick C1 (NPC1), a late endosomal, integral membrane p
rotein that plays a role in cholesterol transport or homeostasis. Biochemic
al diagnosis of NPC has relied on the use of patient skin fibroblasts in an
assay to demonstrate delayed low-density lipoprotein (LDL)-derived cholest
erol esterification and a cytological technique-filipin staining-to demonst
rate the intracellular accumulation of cholesterol. A small percentage of p
atients, referred to as "NPC variants," present with clinical symptoms of N
PC but show near-normal results of these biochemical tests, making laborato
ry confirmation of NPC disease problematic. Here, we demonstrate that NPC-v
ariant fibroblast samples can be detected as sphingolipid storage disease c
ells, using a fluorescent sphingolipid analog, BODIPY-lactosylceramide. Thi
s lipid accumulated in endosomes/lysosomes in variant cells preincubated wi
th LDL cholesterol but targeted to the Golgi complex in normal cells under
these conditions. The reproducibility of this technique was validated in a
blinded study. In addition, we performed mutation analysis of the NPC1 gene
in NPC variant and "classical" NPC cell samples and found a high incidence
of specific mutations within the cysteine-rich region of NPC1 in variants.
We also found that 5 of the 12 variant cell samples had no apparent defect
in NPC1 but were otherwise indistinguishable from other variant cells. Thi
s is a surprising result, since, in general, similar to 90% of patients wit
h NPC possess defects in NPC1. Our findings should be useful for the detect
ion of NPC variants and also may provide significant new insight regarding
NPC1 genotype/phenotype correlations.